Posterior Pituitary

Michael Wilkinson; S. Ali Imran

doi:10.1017/9781108149938.010

Chapter 9 - Posterior Pituitary

Published online by Cambridge University Press: 24 December 2018

Michael Wilkinson and

S. Ali Imran

Show author details

Michael Wilkinson: Affiliation:
Dalhousie University, Nova Scotia
S. Ali Imran: Affiliation:
Dalhousie University, Nova Scotia

Book contents

Get access

Type: Chapter
Information: Clinical Neuroendocrinology
An Introduction
, pp. 154 - 170

DOI: https://doi.org/10.1017/9781108149938.010 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Afsar, B. (2017). Pathophysiology of copeptin in kidney disease and hypertension. Clin Hypertension 23, 13.Google Scholar

Babey, M, Kopp, P & Robertson, G L. (2011). Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Revs Endocr 7, 701–714.Google Scholar

Ball, S G. (2017). The neurohypophysis: endocrinology of vasopressin and oxytocin. www.endotext.org.Google Scholar

Barber, S M, Liebelt, B D & Baskin, D S. (2014). Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3, 1199–1219.Google Scholar

Baskaran, C, Plessow, F, Silva, L et al. (2017). Oxytocin secretion is pulsatile in men and is related to social-emotional functioning. Psychoneuroendocr 85, 28–34.CrossRef Google Scholar PubMed

Berl, T. (2015). Vasopressin antagonists. New Engl J Med 372, 2207–2216.Google Scholar

Bershad, A K, Kirkpatrick, M G, Seiden, J A & de Wit, H. (2015). Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol 35, 308–312.Google Scholar

Besser, G M & Thorner, M O. (2002). Comprehensive Clinical Endocrinology, 3rd Edition (St. Louis, MO: Mosby).Google Scholar

Bhandari, SS, Loke, I, Davies, JE, Squire, IB, Struck, J & Ng, LL. (2009). Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci 116, 257–263.Google Scholar

Blevins, J E, Graham, J L, Morton, G J et al. (2015). Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol 308, R431–R438.Google Scholar

Boccia, M L, Petrusz, P, Suzuki, K, Marson, L & Pedersen, C A. (2013). Immunohistochemical localization of oxytocin receptors in human brain. Neurosci 253, 155–164.Google Scholar

Brimdyr, K, Cadwell, K, Widström, A-M et al. (2015). The association between common labor drugs and suckling when skin-to-skin during the first hour after birth. Birth 42, 319–328.Google Scholar

Burckhardt, M A, Wellmann, M, Fouzas, S et al. (2014). Sexual disparity of copeptin in healthy newborn infants. J Clin Endocr Metab 99, E1750–E1753.Google Scholar

Capatina, C, Paluzzi, A, Mitchell, R & Karavitaki, N. (2015). Diabetes insipidus after traumatic brain injury. J Clin Med 4, 1448–1462.Google Scholar

Carmichael, M S, Humbert, R, Dixen, J, Palmisano, G, Greenleaf, W & Davidson, J M. (1987). Plasma oxytocin increases in the human sexual response. J Clin Endocr Metab 64, 27–31.Google Scholar

Chard, T. (1989). Fetal and maternal oxytocin in human parturition. Am J Perinatol 6, 145–152.Google Scholar

Christ-Crain, M & Fenske, W. (2016). Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Revs Endocr 12,168–176.Google Scholar

Cobo, E. (1973). Effect of different doses of ethanol on the milk-ejecting reflex in lactating women. Am J Obs Gynecol 115, 817–821.CrossRef Google Scholar PubMed

Coiro, V, Alboni, A, Gramellini, D et al. (1992 ). Inhibition by ethanol of the oxytocin response to breast stimulation in normal women and the role of endogenous opioids. Acta Endocr 126, 213–216.Google Scholar

de Jong, T R, Menon, R, Bludau, A et al. (2015). Salivary oxytocin concentrations in response to running, sexual self-stimulation, breastfeeding and the TSST: the Regensburg Oxytocin Challenge (ROC) study. Psychoneuroendocr 62, 381–388.Google Scholar

Dudás, B, Semeniken, K R & Merchenthaler, I. (2006). Morphological substrate of the catecholaminergic input of the vasopressin neuronal system in humans. J Neuroendocr 18, 895–901.Google Scholar

Dumais, K M & Veenema, A H. (2016). Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior. Front Neuroendocr 40, 1–23.Google Scholar

Fenske, W, Sandner, B & Christ-Crain, M. (2016). A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. Best Prac Res Clin Endocr Metab 30, 219–233.CrossRef Google Scholar PubMed

Fenske, W K, Schnyder, I, Koch, G et al. (2018a). Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers. J Clin Endocr Metab 103, 505–513.Google Scholar

Fenske, W, Refardt, J, Chifu, I et al. (2018b). A copeptin-based approach in the diagnosis of diabetes insipidus. New Engl J Med 379, 428–439.CrossRef Google Scholar PubMed

Freeman, S M, Smith, A L, Goodman, M M & Bales, K L. (2017). Selective localization of OXYtocin receptors and vasopressin 1a receptors in the human brainstem. Social Neurosci 12, 113–123.Google Scholar

Fuchs, A R, Romero, R, Keefe, D, Parra, M, Oyarzun, E & Behnke, E. (1991). Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165, 1515–1523.Google Scholar

Fuxe, K, Andersson, K, Eneroth, P, Härfstrand, A & Agnati, L F. (1989). Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocr 14, 19–41.Google Scholar

Giel, K, Zipfel, S & Hallschmid, M. (2017). Oxytocin and eating disorders: a narrative review on emerging findings and perspectives. Curr Neuropharmacol 16, 1111–1121.Google Scholar

Hammer, M & Engell, H C. (1982). Episodic secretion of vasopressin in man. Acta Endocr 101, 517–523.Google Scholar

Hrabovszky, E, Kallo, I, Steinhauser, A, Merchenthaler, I, Coen, C W, Petersen, S L & Liposits, Z. (2004). Estrogen receptor-β in oxytocin and vasopressin neurons of the rat and human hypothalamus: immunocytochemical and in situ hybridization studies. J Comp Neurol 473, 315–333.Google Scholar

Iovino, M, Giagulli, V A, Licchelli, B, Iovino, E, Guastamacchia, E & Triggiani, V. (2016). Synaptic inputs of neural afferent pathways to vasopressin- and oxytocin-secreting neurons of supraoptic and paraventricular hypothalamic nuclei. Endocr Metab Imm Disord: Drug Targets 16, 276–287.Google Scholar

Ishunina, T A & Swaab, D F. (1999). Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus; size changes in relation to age and sex. J Clin Endocr Metab 84, 4637–4644.Google Scholar

Jean-Alphonse, F, Perkovska, S, Frantz, M-C et al. (2009). Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 20, 2190–2203.Google Scholar

Jordan, D, Tafani, J A M, Ries, C et al. (1996). Evidence for multiple opioid receptors in the human posterior pituitary. J Neuroendocr 8, 883–887.Google Scholar

Kendrick, K M, Guastella, A J & Becker, B. (2017). Overview of human oxytocin research. Curr Topics Behav Neurosci 35, 321–348.Google Scholar

Kim, S H, Bennett, P R & Terzidou, V. (2017). Advances in the role of oxytocin receptors in human parturition. Mol Cell Endocr 449, 56–63.Google Scholar

Kirkpatrick, M G, Francis, S M, Lee, R, de Wit, H & Jacob, S. (2014). Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocr 46, 23–31.Google Scholar

Krüger, T H C, Haake, P, Chereath, D et al. (2003). Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocr 177, 57–64.Google Scholar

Lawson, E A. (2017). The effects of oxytocin on eating behaviour and metabolism in humans. Nat Revs Endocr 13, 700–709.Google Scholar

Lawson, E A, Marengi, D A, DeSanti, R L, Holmes, T M, Schoenfeld, D A & Tolley, C J. (2015). Oxytocin reduces caloric intake in men. Obesity 23, 950–956.Google Scholar

Lee, R, Garcia, F, van de Kar, L D, Hauger, R D & Coccaro, E F. (2003). Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. Psych Res 118, 129–136.Google Scholar

Leng, G & Ludwig, M. (2016). Intranasal oxytocin: myths and delusions. Biol Psych 79, 243–250.Google Scholar

Lewandowski, K C & Brabant, G. (2016). Potential clinical utility of copeptin (C-terminal provasopressin) measurements in clinical medicine. Exp Clin Endocr Diabetes 124, 173–177.Google Scholar

Libber, S, Harrison, H & Spector, D. (1986). Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 108, 305–311.Google Scholar

Lucas, J W & Zada, G. (2012). Imaging of the pituitary and parasellar region. Semin Neurol 32, 320–331.Google Scholar

McNeilly, A S, Robinson, I C, Houston, M J & Howie, P W. (1983). Release of oxytocin and prolactin in response to suckling. Br Med J 286, 257–259.Google Scholar

Meyer-Lindenberg, A, Domes, G, Kirsch, P & Heinrichs, M. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Revs Neurosci 12, 524–538.Google Scholar

Miller, G. (2013). The promise and perils of oxytocin. Science 339, 267–269.Google Scholar

Morgenthaler, N G, Struck, J, Jochberger, S & Dünser, M W. (2008). Copeptin: clinical use of a new biomarker. Trends Endocr Metab 19, 43–49.Google Scholar

Morris, M S, Domino, E F & Domino, S E. (2010). Opioid modulation of oxytocin release. J Clin Pharmacol 50, 1112–1117.Google Scholar

Nissen, E, Uvnäs-Moberg, K, Svensson, K, Stock, S, Widström, A-M & Winberg, J. (1996). Different patterns of oxytocin, prolactin but notcortisol release during breastfeeding in women delivered by Caesarean section or by the vaginal route. Early Hum Develop 45, 103–118.Google Scholar

Olszewski, P K, Klockars, A & Levine, A S. (2017). Oxytocin and potential benefits for obesity treatment. Curr Opin Endocr Diabetes Obes 24, 320–325.Google Scholar

Ott, V, Finlayson, G, Lehnert, H et al. (2013). Oxytocin reduces reward-driven food intakein humans. Diabetes 62, 3418–3425.Google Scholar

Olza-Fernández, I, Gabriel, M A N, Gil-Sanchez, A, Garcia-Segura, L M & Arevalo, M A. (2014). Neuroendocrinology of childbirth and mother–child attachment: the basis of an etiopathogenic model of perinatal neurobiological disorders. Front Neuroendocr 35, 459–472.Google Scholar

Parker, K J, Oztan, O, Libove, R A et al. (2017). Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism. Proc Nat Acad Sci USA 114, 8119–8124.Google Scholar

Radant, A, Peskind, E R, Wilkinson, C W et al. (1992). Neurohypophyseal and pituitary-adrenocortical responses to the alpha-1 agonist methoxamine in humans. Neuroendocr 55, 361–366.Google Scholar

Robertson, G L. (2006). Regulation of arginine vasopressin in the syndromeof inappropriate antidiuresis. Am J Med 119, S36–S42.Google Scholar

Rondon-Berrios, H & Berl, T. (2016). Vasopressin receptor antagonists: characteristics and clinical role. Best Prac Res Clin Endocr Metab 30, 289–303.Google Scholar

Rondon-Berrios, H & Berl, T. (2017). Vasopressin receptor antagonists in hyponatremia: uses and misuses. Front Med 4, 141.Google Scholar

Scantamburlo, G, Hansenne, M, Fuchs, S et al. (2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocr 30, 839–845.Google Scholar

Semeniken, K, Merchenthaler, I, Hua, W & Dudás, B. (2009). Catecholaminergic input to the oxytocin neurosecretory system in the human hypothalamus. J Chem Neuroanat 37, 229–233.Google Scholar

Shen, H. (2015). The hard science of oxytocin. Nature 522, 410–412.Google Scholar

Shilling, P D & Feifel, D. (2016). Potential of oxytocin in the treatment of schizophrenia. CNS Drugs 30, 193–208.Google Scholar

Simmler, L D, Hysek, C M & Liechti, M E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocr Metab 96, 2844–2850.Google Scholar

Sladek, C D & Kapoor, J R. (2001). Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Exp Neurol 171, 200–209.Google Scholar

Sofroniew, M V, Weindl, A, Schrell, U & Wetzstein, R. (1981). Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochem Suppl 24, 79–95.Google Scholar

Sukhov, R R, Walker, L C, Rance, N E, Price, D L & Young, WS III. (1993). Vasopressin and oxytocin gene expression in the human hypothalamus. J Comp Neurol 337, 295–306.Google Scholar

Tauber, M, Boulanouar, K, Diene, G et al. (2017). The use of oxytocin to improve feeding and social skills in infants with Prader–Willi syndrome. Pediatrics 139, e20162976.Google Scholar

Ueda, T, Yokoyama, Y, Irahara, M & Aono, T. (1994). Influence of psychological stress on suckling-induced pulsatile oxytocin secretion. Obstet Gynecol 84, 259–262.Google Scholar

Vasicka, A, Kumaresan, P, Hans, G S & Kumaresan, M. (1978). Plasma oxytocin in initiation of labor. Am J Obstet Gynecol 130, 263–273.Google Scholar PubMed

Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Revs 31, 98–132.Google Scholar

Weiskopf, R B, Reid, I A, Fisher, D M, Holmes, M A, Rosen, J I & Keil, L C. (1987). Effects of fentanyl on vasopressin secretion in human subjects. J Pharmacol Exp Therap 242, 970–973.Google Scholar

Wood, C M, Butler, R J, Penney, M D & Holland, P C. (1994). Pulsatile release of arginine vasopressin (AVP) and its effect on response to desmopressin in enuresis. Scand J Urol Nephrol Suppl 163, 93–101.Google Scholar

Young, L J & Barrett, C E. (2015). Can oxytocin treat autism? Science 347, 825–826.Google Scholar

Zhang, H, Wu, C, Chen, Q, Chen, X, Xu, Z, Wu, J & Cai, D. (2013). Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS ONE 8, e61477.Google Scholar

Book contents

Chapter 9 - Posterior Pituitary

Access options

References

Further Reading

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive